These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11888551)

  • 1. Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine.
    Smith MI; Piper DC; Duxon MS; Upton N
    Pharmacol Biochem Behav; 2002 Apr; 71(4):599-605. PubMed ID: 11888551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
    Kantor S; Jakus R; Molnar E; Gyongyosi N; Toth A; Detari L; Bagdy G
    J Pharmacol Exp Ther; 2005 Nov; 315(2):921-30. PubMed ID: 16085759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB-236057-A: a selective 5-HT1B receptor inverse agonist.
    Roberts C; Watson J; Price GW; Middlemiss DN
    CNS Drug Rev; 2001; 7(4):433-44. PubMed ID: 11830759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
    Jakus R; Graf M; Juhasz G; Gerber K; Levay G; Halasz P; Bagdy G
    Exp Neurol; 2003 Dec; 184(2):964-72. PubMed ID: 14769389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses.
    Berg KA; Navailles S; Sanchez TA; Silva YM; Wood MD; Spampinato U; Clarke WP
    J Pharmacol Exp Ther; 2006 Oct; 319(1):260-8. PubMed ID: 16807362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505.
    Kantor S; Jakus R; Balogh B; Benko A; Bagdy G
    Br J Pharmacol; 2004 Aug; 142(8):1332-42. PubMed ID: 15265808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain.
    Tordera R; Pei Q; Newson M; Gray K; Sprakes M; Sharp T
    Neuropharmacology; 2003 Jun; 44(7):893-902. PubMed ID: 12726821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
    Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.
    Nic Dhonnchadha BA; Ripoll N; Clénet F; Hascoët M; Bourin M
    Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.
    Starr KR; Price GW; Watson JM; Atkinson PJ; Arban R; Melotto S; Dawson LA; Hagan JJ; Upton N; Duxon MS
    Neuropsychopharmacology; 2007 Oct; 32(10):2163-72. PubMed ID: 17356576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
    Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T
    J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B; Ursin R
    Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.
    Maura G; Marcoli M; Pepicelli O; Rosu C; Viola C; Raiteri M
    Br J Pharmacol; 2000 Aug; 130(8):1853-8. PubMed ID: 10952674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats.
    Overstreet DH; Knapp DJ; Moy SS; Breese GR
    Psychopharmacology (Berl); 2003 Jun; 167(4):344-52. PubMed ID: 12677355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.